Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cumberland Pharmaceuticals (CPIX) Leases (2019 - 2026)

Cumberland Pharmaceuticals' Leases history spans 7 years, with the latest figure at $8.3 million for Q4 2025.

  • On a quarterly basis, Leases rose 35.08% to $8.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.3 million, a 35.08% increase, with the full-year FY2025 number at $8.3 million, up 35.08% from a year prior.
  • Leases hit $8.3 million in Q4 2025 for Cumberland Pharmaceuticals, up from $7.6 million in the prior quarter.
  • Over the last five years, Leases for CPIX hit a ceiling of $8.3 million in Q4 2025 and a floor of $219850.0 in Q3 2022.
  • Historically, Leases has averaged $4.6 million across 5 years, with a median of $6.2 million in 2024.
  • Biggest five-year swings in Leases: crashed 82.85% in 2022 and later skyrocketed 2952.61% in 2023.
  • Tracing CPIX's Leases over 5 years: stood at $1.0 million in 2021, then skyrocketed by 409.51% to $5.2 million in 2022, then increased by 27.9% to $6.7 million in 2023, then fell by 7.45% to $6.2 million in 2024, then surged by 35.08% to $8.3 million in 2025.
  • Business Quant data shows Leases for CPIX at $8.3 million in Q4 2025, $7.6 million in Q3 2025, and $7.1 million in Q2 2025.